Online citations, reference lists, and bibliographies.
← Back to Search

Enalaprilat And Enalapril Maleate Eyedrops Lower Intraocular Pressure In Rabbits

T. Loftsson, Sigridur Thorisdóttir, H. Fridriksdóttir, E. Stefánsson
Published 2010 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Purpose:  This study aimed to develop low‐viscosity aqueous eyedrops containing enalaprilat and its prodrug enalapril maleate in solution, and to evaluate the eyedrops in rabbits.
This paper references
Diabetic nephropathy and anaemia
E. Ritz (2005)
Cyclodextrins in ophthalmic drug delivery.
Loftssona (1999)
Nerve conduction velocity and evoked potential latencies in strep - tozotocin - diabetic rats : effects of treatment with an angiotensin - converting enzyme inhibitor
SM Manschot (2003)
Effect of enalapril on the incidence of retinopathy in normotensive patients with type 2 diabetes
R. Rachmani (2000)
Vascular outcome in type 2 diabetes: an ADVANCE?
N. Kaplan (2007)
Handbook on Injectable Drugs
L. Trissel (1983)
Cyclodextrins in eye drop formulations: enhanced topical delivery of corticosteroids to the eye.
T. Loftsson (2002)
Topical drug delivery to the posterior segment of the eye: anatomical and physiological considerations.
T. Loftsson (2008)
Topical and systemic absorption in delivery of dexamethasone to the anterior and posterior segments of the eye.
H. Sigurdsson (2007)
Appendix II . Design and optimization of dosage regiments : pharmacokinetic data
KE Tummel (2001)
Enalapril maleate
DP Ip (1987)
Enalapril and diltiazem co-administration and respiratory side effects of enalapril.
S. Fraňová (2005)
Prostaglandins mediate the ocular hypotensive action of the angiotensin converting enzyme inhibitor MK-422 (enalaprilat) in African green monkeys.
V. Lotti (1990)
Nerve conduction velocity and evoked potential latencies in streptozotocin‐diabetic rats: effects of treatment with an angiotensin converting enzyme inhibitor
S. Manschot (2003)
Nerve conduction velocity and evoked potential latencies in streptozotocin-diabetic rats: effects of treatment with an angiotensin-converting enzyme
SM Manschot (2003)
Cyclodextrins as pharmaceutical solubilizers.
M. Brewster (2007)
Cyclodextrins in ocular drug delivery: theoretical basis with dexamethasone as a sample drug
T. Loftsson (2007)
Topical ocular hypotensive effects of the novel angiotensin converting enzyme inhibitor SCH 33861 in conscious rabbits.
R. W. Watkins (1987)
Angiotensin-converting enzyme inhibitors, antagonists and calcium blockers
M Harrold (2007)
Effects of cyclodextrins on drug delivery through biological membranes.
T. Loftsson (2007)
Applied biopharmaceutics and pharmacokinetics
L. Shargel (1980)
Study of forced degradation behavior of enalapril maleate by LC and LC-MS and development of a validated stability-indicating assay method.
S. Bhardwaj (2008)
Clarke's analysis of drugs and poisons
A. Moffat (2003)

This paper is referenced by
Trabecular meshwork ECM remodeling in glaucoma: could RAS be a target?
Puneet Agarwal (2018)
Local ocular renin–angiotensin–aldosterone system: any connection with intraocular pressure? A comprehensive review
Mervi Holappa (2020)
Intraocular pressure lowering effect and structure‐activity relationship of imidazo[1,2‐a]benzimidazole and pyrimido[1,2‐a]benzimidazole compounds in ocular normotensive rats: Insight on possible link with hypotensive activity
A. J. Marcus (2018)
Ocular Inserts for Sustained Release of the Angiotensin-Converting Enzyme 2 Activator, Diminazene Aceturate, to Treat Glaucoma in Rats
G. Foureaux (2015)
Medical treatment of glaucoma: present and future
P. Fogagnolo (2011)
Pharmaceutical applications of cyclodextrins: effects on drug permeation through biological membranes
T. Loftsson (2011)
Cyclodextrins and topical drug delivery to the anterior and posterior segments of the eye.
T. Loftsson (2017)
LC–MS/MS assay for quantitation of enalapril and enalaprilat in plasma for bioequivalence study in Indian subjects
D. Halder (2017)
Development of eye drops containing antihypertensive drugs: formulation of aqueous irbesartan/γCD eye drops
P. Jansook (2015)
Baseline toxicity and ion-trapping models to describe the pH-dependence of bacterial toxicity of pharmaceuticals.
Andreas Baumer (2017)
A Novel Topical Ophthalmic Formulation to Mitigate Acute Mustard Gas Keratopathy In Vivo: A Pilot Study
R. Tripathi (2020)
Mechanisms of angiotensin converting enzyme inhibitor-induced IOP reduction in normotensive rats.
R. Agarwal (2014)
Effect of SPP 635, a renin inhibitor, on intraocular pressure in glaucomatous monkey eyes.
Rongfang Wang (2012)
Semantic Scholar Logo Some data provided by SemanticScholar